Navigation Links
Sangart Raises Additional $50M Series G Funding Following Interim Safety Analysis Of Phase 2b Study Of MP4OX In Severe Trauma Patients With Hemorrhagic Shock
Date:5/24/2012

elop therapies for patients in crisis who are experiencing ischemia (oxygen deprivation of tissues) and organ dysfunction as a result of hemorrhagic shock injury or a vaso-occlusive crisis associated with sickle cell disease.

About Sangart
Sangart is a global biopharmaceutical company dedicated to developing and commercializing targeted rescue therapies for patients in acute ischemic crisis. Sangart's therapies are designed to help patients with medical conditions that cause ischemia, such as hemorrhagic shock and sickle cell disease.

To learn more about Sangart, please visit the company's website at www.sangart.com.

Media Contact:
Vivian Cabral
Edelman Public Relations
Office: 323-202-1032
vivian.cabral@edelman.com

 


'/>"/>
SOURCE Sangart, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sangart, Inc. Receives $1.1 Million Grant Award from the United States Department of Defense for Further Development of MP4 Molecule in Trauma
2. Sangart, Inc. Reports Positive Phase IIa Data for Novel Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients
3. Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease
4. Sangart, Inc. Completes Series F Funding Round
5. Sangart, Inc. Announces Key Executive Appointments and Company Restructuring
6. Cerecor Raises $22 Million Series A Financing
7. Biotech Firm Spun Off from Childrens Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment
8. Cowen Healthcare Royalty Partners Raises $1 Billion
9. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
10. DLVR Therapeutics Inc. Raises Additional Capital Adding MaRS Innovation to Investor Base
11. Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 FemCap Inc., ... health announces its receipt of a patent No: US, ... cup has also received FDA clearance in the U.S., ... the CE in Europe. This patent is related to its ... this issuance, the company is releasing FemmyCycle Teen, a ...
(Date:9/30/2014)... The custom stainless steel fabrication company HOLLOWAY AMERICA ... Boston Area Chapter of ISPE (International Society for Pharmaceutical ... Wed., Oct. 1 at Gillette Stadium Clubhouse in Foxborough, ... ISPE Boston’s long history, with more than 375 exhibitors ... , HOLLOWAY AMERICA President David Simpson is looking forward ...
(Date:9/30/2014)... Windsor, CT (PRWEB) September 30, 2014 ... distributor of scientific research products, recently opened an ... its comprehensive cell culture product lines developed and ... through its online store include Biological Industries’ Nutristem® ... (hMSC) and human embryonic stem cell (hESC) culture. ...
(Date:9/30/2014)... Whitehouse, New Jersey (PRWEB) September 30, 2014 ... that it has been chosen by the Parenteral ... course (November 18 and 19, 2014) on container closure ... current container closure integrity test methods and philosophies detailed ... Product – Integrity Evaluation. The course will ...
Breaking Biology Technology:The FemmyCycle 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 3Rainbow Scientific, Inc. opens online store for state-of-the-art stem cell culture and cytogenetic reagents 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 3Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 4
... April 13, 2011 Today Massachusetts Life Sciences Center ... officials,  Organogenesis, Inc. President & CEO Geoff MacKay and ... Dan Road.  Upon completion in 2013, the company expects ... cell manufacturing plant.   Organogenesis is in ...
... Biosciences, a global manufacturer of products designed to ... labor intensive, today announced an agreement with Bruker ... microbial identification from cultures using MALDI-TOF proteomic finger-printing, ... research, and veterinary laboratory customers. The compatible product ...
... published in the March 14 edition of the ... and testing of a new type solar cell using ... nanowires (described has "quantum coaxial cables") had previously been ... chemically more stable large bandgap inorganic materials, should also ...
Cached Biology Technology:Organogenesis, Life Sciences Center Break Ground on World's Largest Automated Living Cell Manufacturing Plant 2Organogenesis, Life Sciences Center Break Ground on World's Largest Automated Living Cell Manufacturing Plant 3Organogenesis, Life Sciences Center Break Ground on World's Largest Automated Living Cell Manufacturing Plant 4Magellan Biosciences Announces Agreement with Bruker to Provide Microbiology Tools to Battle Drug Resistance 2Magellan Biosciences Announces Agreement with Bruker to Provide Microbiology Tools to Battle Drug Resistance 3Magellan Biosciences Announces Agreement with Bruker to Provide Microbiology Tools to Battle Drug Resistance 4Device proves solar cell potential of high bandgap inorganic nanowire arrays 2Device proves solar cell potential of high bandgap inorganic nanowire arrays 3
(Date:9/30/2014)... all have in common? Unlike most eukaryotic multicellular ... diploid, these organisms are all polyploid, meaning they have ... have 3 and 4 sets of chromosomes, respectively, and ... in fact most plant species are polyploid. Polyploidy, or ... but only recently, with the development of molecular tools, ...
(Date:9/30/2014)... professor and Howard Hughes Medical Institute investigator, and ... recipients in the 2014 round of grants from ... BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative ... September 30, provides more than $3 million in ... , The BRAIN Initiative, launched last year, is ...
(Date:9/30/2014)... of Medicine reports positive results of a phase ... subset of lung cancer marked by rearrangement of the ... with advanced non-small cell lung cancer testing positive for ... with 3 complete responses and 33 partial responses. Median ... disease to resume its growth after being slowed by ...
Breaking Biology News(10 mins):Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 3Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 4Salk scientists receive $3 million for BRAIN Initiative grant 2NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2
... bites, and business struggle to stay primed, researchers in ... and business practice is needed if a company is ... Practice from Inderscience Publishers, the team explains how businesses ... Palmira Lpez-Fresno of "STIGA" in Barcelona is working ...
... An undergraduate student at Rensselaer Polytechnic Institute has learned ... help the medicine go down. In fact, with his ... Among the most important and complex molecules in the ... how cells communicate with one another. Graduating senior Jeffery ...
... discovery of the duck-billed, egg-laying, otter-footed, beaver-tailed, venomous platypus ... must be a hoax. Sketches of its appearance were ... that the oddness of the platypus, looks isn,t just ... avian, reptilian and mammalian lineages that may hold clues ...
Cached Biology News:Programmed death boosts business 2Undergrad has sweet success with invention of artificial Golgi 2Undergrad has sweet success with invention of artificial Golgi 3Platypus genome decoded 2Platypus genome decoded 3
Mouse polyclonal antibody raised against a partial recombinant TSEN2. NCBI Entrez Gene ID = 80746...
Mouse polyclonal antibody raised against a partial recombinant NCLN. NCBI Entrez Gene ID = 56926...
Mouse monoclonal antibody raised against a partial recombinant FBXO11. NCBI Entrez Gene ID = FBXO11...
Mouse polyclonal antibody raised against a partial recombinant COASY. NCBI Entrez Gene ID = 80347...
Biology Products: